Table 3.
< 65 years (N = 66) | ≥ 65 years (N = 40) | ||||||
---|---|---|---|---|---|---|---|
Variable (frail vs. non-frail) | Odds Ratio | 95% Confidence Interval | P value | Odds Ratio | 95% Confidence Interval | P value | P value for age difference |
Seroprotection at Day 21a | |||||||
H1N1 A/California/07/2009 | 8.79 | 1.78 – 43.31 | 0.008** | 0.54 | 0.12 – 2.52 | 0.43 | 0.009* |
H3N2 A/Texas/50/2012 | 6.00 | 1.25 – 28.75 | 0.02* | 0.36 | 0.06 – 1.99 | 0.23 | 0.014* |
B/Massachusetts/2/2012 | 7.79 | 1.15 – 52.61 | 0.03* | 0.46 | 0.05 – 4.67 | 0.51 | 0.05 |
Seroconversionb | |||||||
H1N1 A/California/07/2009 | 6.86 | 1.55 – 30.37 | 0.011* | 0.75 | 0.17 – 3.30 | 0.70 | 0.045* |
H3N2 A/Texas/50/2012 | 5.85 | 1.86 – 18.40 | 0.003** | 0.29 | 0.05 – 1.73 | 0.17 | 0.005** |
B/Massachusetts/2/2012 | 2.68 | 0.81 – 8.78 | 0.107 | 0.61 | 0.14 – 2.68 | 0.51 | 0.221 |
Log2 D21 HAI antibody titersc | |||||||
H1N1 A/California/07/2009 | 0.55 | 0.15 | <0.001** | 0.06 | 0.25 | 0.82 | 0.06 |
H3N2 A/Texas/50/2012 | 0.50 | 0.17 | 0.005** | −0.26 | 0.17 | 0.15 | 0.002** |
B/Massachusetts/2/2012 | 0.29 | 0.14 | 0.05 | −0.17 | 0.14 | 0.23 | 0.04* |
significant at P value <0.05
significant after adjusting for multiple comparisons 0.05/6, P value 0.0083
aLogistic Regression: Event sizes for Seroprotecting at Day 21: H1N1 (N = 38 <65 years; N = 22 ≥65 years); H3N2: (N = 48 <65 years; N = 21 ≥65 years); B: (N = 51 <65 years; N = 29 ≥65 years)
bLogistic Regression: Event sizes for Seroconverting: H1N1 (N = 13 <65 years; N = 11 ≥65 years); H3N2: (N = 25 <65 years; N = 9 ≥65 years); B: (N = 19 <65 years; N = 12 ≥65 years)
cLinear regression equation: Log2 D21 HAI titer = B0 + B1*Frail + B2*BMI + B3*log2 baseline titer +E